Medical Equipment Financing: Why a 3% Supply Increase Is Really a 15% Capital Problem

October 24, 2026 | 1:00 p.m. ET

SEO Title: Medical Equipment Financing | White Coat Financial Partners

Meta Description: Planning equipment spend for 2027? With med-surg prices rising about 3% a year, here is how to add capacity without draining cash.

A roughly 3% annual increase in medical-surgical supply prices may sound manageable, but over five years it can become a roughly 15% cost increase and a much larger capital-planning challenge. Medical Equipment Financing should account for more than the machine’s purchase price: it should also address the supplies, service, and case-related costs needed to put that asset to work. That is why Medical Equipment Financing belongs in the same plan as working capital.

Key takeaway: Before signing a purchase order, use cash position analysis to model the equipment and its operating costs together. Leasing the asset while using AR-Backed Working Capital for an operating gap may help preserve liquidity for both.

Medical Equipment Financing: The 3% That Becomes 15%

The Journal of Healthcare Contracting reported Vizient’s forecast of roughly 3.03% med-surg supply inflation over the next year. Steven Lucio of Vizient illustrated the five-year effect: a 3% annual increase adds up to about 15% over five years. That is the planning number to carry into your budget, because a purchase order signed this year locks in an operating cost that keeps growing for every year the asset stays in service.

Vizient’s summer 2026 Spend Management Outlook puts medical and surgical products at 3.05%, including medical supplies at 3.21% and surgical supplies at 2.62%. It also identifies exposure to raw materials, tariffs, logistics, and supply volatility. A one-year bid can inform an order, but it cannot substitute for a multi-year budget.

For financial planning, model the expected cost of consumables, service, and utilization alongside the asset. This is forward looking financing: align the capital plan with the cash demands the equipment will generate.

Why Equipment and Consumables Compete for the Same Cash

A robotics, imaging, or AI-enabled diagnostic system may require significant upfront capital and continuing operating spend. Depending on the service line, that may include disposables, preference items, maintenance, and service contracts. If the machine is financed without planning for these costs, the purchase can create two simultaneous demands on cash.

The market context reinforces the need for deliberate capital optimization. EY’s 2026 Pulse of the MedTech Industry report describes continued sector growth and expansion into alternative care settings, particularly ambulatory surgery centers. EY also notes that AI is being embedded into devices and care pathways. As clinics and ASCs consider new capacity, equipment and case-related costs should be evaluated together.

Supply resilience is also relevant to the budget. Healthcare Purchasing News reported that BD committed $19 billion to enhance domestic medical consumables manufacturing. That announcement signals investment in supply capacity; it does not establish when buyers will see increased availability or lower prices. Strategic capital management should therefore account for uncertainty as well as the quoted price.

Where Equipment Leasing Fits

A lease pays for the usage of equipment rather than ownership, so the practice can generate revenue from the asset without absorbing depreciation or ownership risk. That distinction is the whole economics of the decision: you are buying the capacity the machine produces, not the machine itself.

Leases with purchase options let a practice cycle into newer imaging, diagnostics, or AI tools at the end of the term. That optionality matters when technology moves faster than the useful life of a major purchase, and it is one reason equipment leasing is a critical tool for practices positioning for an M&A exit or acquisition financing. Buyers and lenders look at obligations, cash flow, and asset needs together, so practice acquisition financing planning belongs in the same conversation as the equipment decision.

The tax and accounting treatment is a genuine advantage here too. Operating leases appear as expenses on the P&L and not as liabilities on the balance sheet, which preserves debt capacity and debt-to-equity ratios. And lessees may deduct the full lease payment as a business expense in the year of payment (check with your tax advisor to see if you qualify).

AR-Backed Working Capital for the Operating Side of the Plan

An equipment lease addresses the asset; AR-Backed Working Capital can help address operating needs while the practice waits for payment. Under White Coat Financial Partners’ non-notification model, your practice keeps its own billing and collections. White Coat Financial Partners does not take possession of receivables, contact patients, or intervene in the billing process.

The lending is based on the aggregate sum of monies due across total receivables, not individual claims. Repayment is structured to align with cash flow, with no compounding interest or open-ended discount rates. Lending is AR-backed and not based solely on personal credit scores. The approach can scale from solo practices to multi-location groups, and approval may be available within 24 to 48 hours.

Explore medical equipment financing and AR-Backed Working Capital as part of a broader medical practice financing review. A cash position analysis can help determine whether the asset and its operating costs fit the practice’s financial health without creating a two-front cash problem.

Pair the Financing With Lean Six Sigma

Financing can address timing; process improvement can address the source of recurring cash pressure. Lean Six Sigma work to shorten the billing cycle may decrease the long-term need for financing, while process discipline helps keep the new asset productive. It frames improvement as a way to find money already earned, not as manufacturing jargon.

✅ Before committing, confirm that your plan accounts for:

The equipment payment and expected operating expenses.
Consumables, service contracts, and case-related costs.
Cash flow timing, lease obligations, and financing options.

Accounting is history. Financing is forward looking. Bring these decisions together through disciplined financial planning and strategic capital management for greater clarity and certainty.

Frequently Asked Questions

Is it better to buy or lease medical equipment in 2027?

It depends on cash position, equipment use, upgrade plans, contract terms, and how the asset fits your capital strategy. Compare total costs and accounting treatment before deciding.

How much should my practice budget for supply inflation?

Vizient’s cited outlook shows roughly 3% annual pressure in several med-surg categories, with different projections by category. Use your own purchasing mix and a multi-year scenario rather than treating a single forecast as a guaranteed practice-level increase.

Will an equipment lease hurt my ability to get acquisition financing?

It may affect lender analysis, depending on lease terms, accounting treatment, covenants, and the transaction. Review the obligation early with your financing and M&A advisors.

Can AR-Backed Working Capital cover both equipment and supply costs?

It can support operating needs, including supply costs, while equipment leasing may finance the asset. A financing review can help determine how the two fit your cash flow and capital plan.

Take the Next Step

White Coat Financial Partners brings unmatched expertise, a gold standard of service, and white-glove services to forward looking financing for healthcare businesses. Start a conversation about Medical Equipment Financing and your broader capital plan through our North Carolina financing page or call 910-688-5077.

About the Author

Stuart D. Anderson is the founder and President of White Coat Financial Partners, a Fayetteville, NC-based firm providing specialized financial and advisory services for healthcare professionals and organizations. With deep expertise in AR-backed working capital, equipment leasing, M&A brokerage, and Lean Six Sigma process optimization, Stuart helps medical practices unlock capital, streamline operations, and achieve long-term financial stability. Connect with Stuart on LinkedIn.

white coat financial partners